Web NewDrugInformation.com

Travasol 5.5% W/ Electrolytes Drug - Travasol 5.5% W/ Electrolytes The trade name of the product as shown on the labeling. Dosage - INJECTABLE; INJECTION The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Amino Acids; Magnesium Chloride; Potassium Phosphate, Dibasic; Sodium Acetate; Sodium Chloride Multiple ingredients are in alphabetical order. Strength - 5.5%;102MG/100ML;522MG/100ML;431MG/100ML;224MG/100ML The potency of the active ingredient(s), Amino Acids; Magnesium Chloride; Potassium Phosphate, Dibasic; Sodium Acetate; Sodium Chloride. May repeat for multiple part products. Applicant - BAXTER HLTHCARE The firm name holding legal responsibility for Travasol 5.5% W/ Electrolytes. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 017493 The FDA assigned number to Travasol 5.5% W/ Electrolytes. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Travasol 5.5% W/ Electrolytes. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Approved Prior to Jan 1, 1982 The date Travasol 5.5% W/ Electrolytes was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Travasol 5.5% W/ Electrolytes. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Travasol 5.5% W/ Electrolytes is in. Format is RX, OTC, DISCN. Applicant Full Name - Baxter Healthcare Corp The full name of the firm holding legal responsibility for the new application of Travasol 5.5% W/ Electrolytes. Travasol 5.5% W/ Electrolytes Aminosyn Ii 7% W/ Electrolytes 7%;102mg/100ml;45mg/100ml;522mg/100ml;410mg/100ml Injectable; Injection Aminosyn Ii 8.5% W/ Electrolytes 8.5%;102mg/100ml;45mg/100ml;522mg/100ml;410mg/100ml Injectable; Injection Aminosyn Ii 3.5% M 3.5%;30mg/100ml;97mg/100ml;120mg/100ml;49mg/100ml Injectable; Injection Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container 3.5%;51mg/100ml;131mg/100ml;218mg/100ml;35mg/100ml Injectable; Injection Travasol 3.5% W/ Electrolytes 3.5%;51mg/100ml;131mg/100ml;218mg/100ml;35mg/100ml Injectable; Injection Travasol 5.5% Sulfite Free W/ Electrolytes In Plastic Container 5.5%;102mg/100ml;522mg/100ml;431mg/100ml;224mg/100ml Injectable; Injection Travasol 5.5% W/ Electrolytes 5.5%;102mg/100ml;522mg/100ml;431mg/100ml;224mg/100ml Injectable; Injection Aminosyn Ii 3.5% M In Plastic Container 3.5%;32mg/100ml;128mg/100ml;222mg/100ml;49mg/100ml Injectable; Injection Veinamine 8% 8%;61mg/100ml;211mg/100ml;56mg/100ml;388mg/100ml Injectable; Injection Aminosyn Ii 10% W/ Electrolytes 10%;102mg/100ml;45mg/100ml;522mg/100ml;410mg/100ml Injectable; Injection NewDrugInformation